Skip to main content

Parkinson's disease may one day be treated by using a virus to reprogram brain cells

A team of scientists at Sweden’s Karolinska Institute have been working on a technique for reprogramming cells in the brain as part of what might one day be a treatment for Parkinson’s disease.

The research involves modifying neurons in the brains of sufferers of Parkinson’s, a long-term degenerative disease of the central nervous system which predominantly affects motor abilities. Up to 1 million Americans live with Parkinson’s disease, a number that’s more than the combined total of people in the U.S. diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrig’s disease.

Recommended Videos

The inability of people with Parkinson’s to properly control their movement is the result of a shortage of dopamine, a chemical which plays an important role in signalling in the brain.

For many years, scientists have attempted to develop a Parkinson’s treatment allowing for lab-grown dopamine neurons to be implanted into the brain. The new research carried out at Karolinska Institute, published in the journal Nature Biotechnology, describes a possible way to do this by changing regular brain cells called astrocytes into ones that resemble dopamine neurons.

The project has been underway for six years, but is only now beginning to deliver on its promise.

In an experiment, a virus engineered to carry four genes for reprogramming astrocytes was injected into the brains of mice. After five weeks, the mice showed significant improvement in motor movements, including areas like walking. There were no unwanted side effects observed.

While there’s still a way to go until this could be used to treat Parkinson’s in humans, there is some evidence to suggest that this might be possible. That is based on the team’s use of the same four genes to convert human astrocytes into dopamine neurons in a dish. The next question to answer is whether this will work as effectively in an older, living human brain. If so, the research may represent a breakthrough in Parkinson’s treatment.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
The Ioniq 5 is once again eligible for the $7,500 tax credit
2025 Hyundai Ioniq 5

After a brief and confusing absence, the Hyundai Ioniq 5 is once again eligible for the full $7,500 federal tax credit — and this time, it's sticking around (at least for now). So, what happened? Let’s unpack the ride.

The Ioniq 5, a sleek and tech-savvy electric crossover, initially made headlines not just for its design, but for being built at Hyundai’s brand-new Metaplant in Georgia. That domestic assembly qualified it for the EV tax credit under the Inflation Reduction Act (IRA), which requires vehicles to be made in North America with batteries sourced from trade-friendly countries. But early in 2025, the Ioniq 5 vanished from the list. Why? Likely due to its battery packs, which were then still being sourced from SK On’s Hungarian facility.

Read more
Sebastian Stan lays out Bucky’s future after Thunderbolts
Sebastian Stan in Thunderbolts.

There are some spoilers ahead for the ending of Marvel's Thunderbolts. Stop reading now if you don't want to be spoiled.

Earlier this year, Captain America: Brave New World briefly introduced a new direction for James "Bucky" Barnes, a character Sebastian Stan has been playing since 2011 in Captain America: The First Avenger. In Brave New World, the former Winter Soldier apparently retired from being a reformed hero and went into politics by running for Congress. Thunderbolts reveals that Bucky won his election to the House of Representatives. But his stay in Congress was short.

Read more
Jeep Compass EV breaks cover—but will it come to the U.S.?
jeep compass ev us newjeepcompassfirsteditionhawaii  4

Jeep just pulled the wraps off the all-new Compass EV, and while it’s an exciting leap into the electric future, there's a catch—it might not make it to the U.S. anytime soon.
This is a brand new electric version of the Jeep Compass, and being built on Stellantis' STLA platform—the same architecture underpinning models like the Peugeot E-3008 and E-5008—it looks much slicker and packs a lot more inside than previous versions of the Compass.
Let’s start with what’s cool: the new Compass EV is packing up to 404 miles of range on a single charge, a 74 kWh battery, and fast-charging that gets you from 20% to 80% in about 30 minutes. Not bad for a compact SUV with Jeep's badge on the nose.
There are two versions: a front-wheel-drive model with 213 horsepower and a beefier all-wheel-drive version with 375 horsepower. That AWD setup isn’t just for looks—it can handle 20% inclines even without front traction, and comes with extra ground clearance and better off-road angles. In short, it’s still a Jeep.
The design's been refreshed too, and inside you’ll find the kind of tech and comfort you’d expect in a modern EV—sleek, smart, and ready for both city streets and dirt trails.
But here’s the thing: even though production starts soon in Italy, Jeep hasn’t said whether the Compass EV is coming to America. And the signs aren’t promising.
Plans to build it in Canada were recently put on hold, with production now delayed until at least early 2026. Some of that might have to do with possible U.S. tariffs on Canadian and Mexican vehicles—adding a layer of uncertainty to the whole rollout.
According to Kelley Blue Book, a Stellantis spokesperson confirmed that the company has “temporarily paused work on the next-generation Jeep Compass, including activities at” the Canadian plant that was originally meant to build the model. They added that Stellantis is “reassessing its product strategy in North America” to better match customer needs and demand for different powertrain options.
So while Europe and other markets are gearing up to get the Compass EV soon, American drivers might be left waiting—or miss out entirely.
That’s a shame, because on paper, this electric Jeep hits a lot of sweet spots. Let’s just hope it finds a way over here.

Read more